-
Infection control professionals adopting policies requiring workers to sign declination statements if they forgo influenza vaccination can expect to run into a persistent group of "refuseniks" with varied reasons for their recalcitrance.
-
Obesity is a major contributor to employee health costs, responsible for 2% to 3% of all medical claims dollars, a new health research report finds.
-
The 55th Annual Scientific Sessions of the American College of Cardiology (ACC; Bethesda, Maryland), held here in mid-March, showcased new developments in a wide range of diagnostic and therapeutic technologies applicable to cardiovascular disease, including interventional device technologies, invasive imaging and diagnosis, technologies for diagnosis and treatment of heart rhythm disorders, and new technologies for stroke treatment.
-
Just before presstime for this issue of Cardiovascular Device Update, Boston Scientific (Natick, Massachusetts) and Guidant (Indianapolis) reported that the FTC granted antitrust approval for their $27.2 billion merger and they expected to finalize the deal April 21.
-
C. R. Bard (Murray Hill, New Jersey) completed its previously reported acquisition of Venetec International (San Diego, California).
-
While most of the biggest headlines in cardiovascular news last year, and so far this year, have been focused on the rhythm management space of cardiovascular devices - pacemakers and implantable cardioverter defibrillators (ICDs) and the problems with those devices - the cardio sector making the most clinical noise probably has been that of ventricular assist devices (VADs).
-
Sorin Group (Milan, Italy) reported receiving CE marking for its new Cobalt Chrome coronary carbostent, the Chrono stent. The company said that Chrono will be fully released in Europe and all the CE mark countries.
-
AGA Medical (Minneapolis), the University of Minnesota Medical School and the Minnesota Medical Foundation reported establishment of the Amplatz Chair in Radiology, a permanently endowed chair at the University of Minnesota Medical School, with AGA Medical donating $2 million in initial funding of the chair.
-
The FDA approved a humanitarian device exemption (HDE) for fetoscopy instrument sets distributed by Karl Storz Endoscopy America (Culver City, California) under the Humanitarian Use Device (HUD) program for the treatment of fetuses with twin-to-twin transfusion syndrome (TTTS).
-
